Join
Live feed
·
PRReleasevia Quantisnow
Forte Biosciences Inc. logo

FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period

ByQuantisnow·Wall Street's wire, on your screen.
FBRX· Forte Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FBRX (Forte Biosciences Inc.) and more on Quantisnow.